Event Schedule
   

Creating  connections  with  KOLs  isn’t  always  easy.  In  the  post-COVID  era,  outreach  can  be particularly  difficult.  Although  many  organizations  prefer  face-to-face  meetings,  virtual meetings  are  here  to  stay  and  many  experts  have  developed  a  preference  for  digital interactions. Now is the time to fine-tune your virtual outreach and take advantage of digital tools.

  • Leverage advisory boards to gather insights
  • Look for flexible discussion tools
  • Seek out experienced vendors
Optimize Your Medical Communication Strategy While Staying Compliant Compliance is a big concern among Medical Affairs professionals when it comes to developing and publishing scientific material. They need new solutions for better, more streamlined content management.
• Reimagine traditional publishing and internal collaborations by identifying compliance
concerns and defining solutions
• Increase the visibility and reach of congress presentations and publications
• Learn how to collaborate with marketing and other internal stakeholders to create
compliant materials or engage with virtual activities to meet goals
Understanding where other companies are at with digital innovation is vital. How do their
companies compare and what learnings can you implement at your own company?
• Share digital strategies that organizations are implementing and how they are
becoming more digital
• Exchange learnings, pitfalls, and best practices
• Discuss available software and what organizations are using
COVID-19 has accelerated digital adoption and reduced Scientific Leaders’ availability prompting new and innovative methods to educate, inform and engage. Being present is not enough, the digital experience needs to be seamless and frictionless through integrated and interoperable omni-channel touchpoints. Join us in our discussion of how to increase your digital footprint and strategically drive value for your scientific leaders.
 
• Discuss omnichannel strategy, learnings and best practices that can help shape the
life sciences industry
• Dive into strategies to engage, educate and inform healthcare professionals at the
click of a button
KOL engagement strategies must take into account how influencers are utilizing digital and
social channels to communicate and response to research. 85% of KOLs have an online
presence. How do you choose the right person to leverage online influence?
 
• Explore how social and didigtal prominence surface within KOL profiles, pipeline
through post marketing
• Considerations for expanding engagement strategies based on KOL social reach,
clinical trials, publications, speakers, etc.
Digital transformation is about more than just introducing new technologies or digital tools.
Transformation requires rethinking old ways of working and adopting new behaviors. Effective
change management is essential for implementing new technologies.
 
• Discuss common challenges encountered during digital transformation in Medical
Affairs using real life examples.
• Share lessons learned and recommendations provided on how to lead a successful
transformation.
   

Many organizations lack clarity and urgency on digital strategy and struggle to locate, attract and retain the digital leadership they require. As leaders in the sector have demonstrated, a greater dependence on digital technologies and data may benefit pharmaceutical companies in  a  variety  of  ways.  You  can  set  your  company  at  an  advantage  by  bringing  digital  savvy experts on board – but what happens if you’re not a digital expert yourself?

  • Discover what to look for, questions to ask, and how to interview 
  • Find talent that has the skillsets and vision for digital transformation
  • Recruit talent from outside of pharma with more digital experience
The need to connect and find support, especially across rare disease communities, has led to
an increasing number of patients and caregivers turning to social media. These disease-
specific communities can provide an important window into the perspective of patient
experience. Maria Picone and Kristina Davison present a case study on expanding advocacy
outreach to these peer-to-peer online support groups.
 
• Gather novel insights that are unsolicited and not subject to response bias that may
occur in surveys and interviews
• Understand what matters most to patients and caregivers in their own words
• Use the patient experience lexicon to shape messaging and marketing
• Assess unmet need to inform strategic initiatives to give back to the communit
The pandemic has significantly impacted Medical Science Liaisons. With vaccines rolling out and travel opening back up, medical affairs leaders are forced to evaluate how these teams should operate in order to bring the best outcomes.
 
• Review trends in the evolution of the MSL role across the industry
• Discuss how to manage change for evolving MSL teams
• Use data to enhance strategy for the new MSL role
• Change existing behavior and adapt to new, innovative tools to add value
• Develop your medical affairs strategy and build effective teams in this new
environment
• Find the appropriate balance between virtual and hybrid engagement
• Determine how to maximize your medical engagements in a hybrid setting
We live in a world where a reader’s attention span is a few seconds and the competition for
customer attention is fierce. HCPs are overwhelmed by the sheer noise of it all. It’s essential to cut through the noise and get the attention of your audience.
 
• Deliver snackable, bite-sized content
• Share your content across the multitude of channels and platforms where HCPs are
• Review real examples of compliant, digestive, and effective content
HCPs are increasingly using social media as a valid and trusted platform for sharing opinions, dispelling misinformation, and furthering their medical knowledge. Many organizations; however, continue to avoid social media platforms due to a lack of knowledge on how to engage effectively in a compliant way. Medical Affairs teams have a great opportunity to become more involved in the scientific exchange that occurs across social media platforms or risk being silenced completely.
  • Learn how to overcome compliance hurdles and engage HCPs successfully on social media
  • Understand the behaviors and preferences of HCPs
  • Collaborate with DOLs to improve the reach and credibility of your messaging on social channels
   
The pandemic has compelled pharmaceutical companies to change their communication channels like never before. While some businesses were able to rapidly pivot to virtual releases and prevent delays, others were caught off guard and unable to respond as quickly. It is critical to develop the necessary skillset and digital infrastructure to compete in this new environment.
  • Discuss best practices, pitfalls and learnings
  • Highlight digital tools that reduce barriers
The transition to value-based care is heavily dependent on evidence-based medicine, and pharmaceutical organizations play a key role in scientific communication across the healthcare ecosystem. Because they operate in a highly regulated industry, experts need to communicate authentic, validated information. In order to accomplish this, they are increasingly turning to patient-centric analytics.
  • Understand where patients are in the system in order to target scientific and clinical information to the clinicians who matter
  • Identify signals in real-world data and use them to pinpoint the doctors who are having the most impact on disease burden
Due to the unique challenges of rare and chronic disease, communities are creating disease-
specific social networks where they support one another and share their personal stories.
These conversations contain rich details that can contribute to a more complete view of
patient experience. Moderated by Maria Picone of TREND Community, The Gout Support
Group of America discusses its findings from an analysis of the anonymized conversations
from their online support group and a public reddit group.
 
• How does the information shared within the private, moderated group compare to
the information shared on public social media?
• What insights were gleaned that were missing or underrecognized in the medical and
scientific literature?
• How did this initiative foster collaboration with pharma?

The most time-consuming and complex aspect of the clinical trial process is patient recruitment and retention. By failing to keep up with how consumers use technology, the industry spends billions of dollars and takes a decade or more to bring new treatments to market. What is your organization doing to effectively recruit and retain patients in a clinical trial?

• Establish a recruiting strategy that reaches patients on all channels

• Tap into the network of social media influencers

• Develop a thorough prescreening questionnaire to recruit high quality patients

  • Discover how people learn in the digital age
  • Discuss current developments in data visualizations tailored to the audience
  • Convey data and pertscientific messages to ensure engaging content for scientific exchange
  • Use analytics to collect metrics, apply learnings and develop tools for cross-functional use